Author

Diego Cea

Universidad Andrés Bello

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

A. Said Álamos-MusreiD· 1 shared Carolina OteroiD· 1 shared Daniel Paredes‐SabjaiD· 1 shared F.B. GiliD· 1 shared Felipe M. LlancalahuéniD· 1 shared Fernando Díaz-YáñeziD· 1 shared Javiera Valeria GallegosiD· 1 shared Juan Muñoz-Miralles· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Said Álamos-MusreORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Repurposing nystatin and taurocholate to target intracellular spore persistence during antibiotic treatment to prevent recurrent Clostridioides difficile infection.

Pablo Castro-Córdova, Maria Mendoza-Leon, A. Said Álamos-Musre, Nicolás Montes-Bravo, Juan Muñoz-Miralles, Fernando Díaz-Yáñez, Felipe M. Llancalahuén, Diego Cea, Rosario Hernández‐Armengol, Javiera Valeria Gallegos, Katherine Mondaca, Carolina Otero, F.B. Gil, Marjorie Pizarro‐Guajardo, Daniel Paredes‐Sabja

This study shows that combining nystatin, taurocholate, and antibiotics, with nanoparticle delivery, reduces recurrent Clostridioides difficile infection by targeting intracellular spores.

bioRxiv · Oct 1, 2026 · PreprintPharmacology & Toxicology